This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Korea Atomic Energy Research Institute. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Daejeon-si, KR (2010)
- Daejeon, KR (2012)
Company Filing History:
Years Active: 2010-2012
Title: Innovations of Sun-Ju Choi in Melanoma Diagnosis and Treatment
Introduction
Sun-Ju Choi is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical diagnostics and treatment, particularly in relation to melanoma. With a total of 2 patents, his work focuses on innovative methods and compositions that enhance the diagnosis and treatment of melanoma tumors.
Latest Patents
One of Sun-Ju Choi's latest patents is titled "Chelating agent conjugated α-MSH peptide derivatives, preparation method thereof and composition for diagnosis and treatment of melanoma comprising the same as an active ingredient." This invention discloses chelating agent-conjugated α-MSH peptide derivatives that are highly selective to the melanocortin-1 receptor, which is expressed in melanoma tumors. The novel derivatives exhibit a high labeling rate of radioactive isotopes and demonstrate a significant uptake in melanoma tumors, making them effective for early diagnosis and treatment.
Another important patent is related to "DTPA derivatives and metal complexes thereof, and radiation source and contrast agent including the metal complexes." This invention focuses on diethylenetriamine pentaacetic acid (DTPA) derivatives that contain iodine and are useful as contrast agents for diagnosing renal function. The metal complexes derived from these DTPA derivatives are safe and cost-effective, as they are excreted via the kidneys and bladder shortly after use.
Career Highlights
Sun-Ju Choi is affiliated with the Korea Atomic Energy Research Institute, where he conducts research and development in the field of medical applications of nuclear technology. His work has been instrumental in advancing the understanding and treatment of melanoma, contributing to improved patient outcomes.
Collaborations
Sun-Ju Choi has collaborated with notable colleagues, including Young-Don Hong and Ok Ja Choi, who have also contributed to the research and development of innovative medical solutions.
Conclusion
Sun-Ju Choi's contributions to the field of melanoma diagnosis and treatment through his innovative patents highlight the importance of research in medical technology. His work continues to pave the way for advancements in effective diagnostic and therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
